David Evan Huw Llewelyn | GMC# 1461192

  • Aneurin Bevan NHS Trust
  • Endocrinologist, general and acute physician (currently doing a long-term locum during retirement)

Archived Declarations


Oct. 16, 2015

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Sanofi Analysing in 2003 the results of a study to examine by Sanofi to see if its recommended indications for use of irbesartan in diabetic albuminuria led to over-diagnosis or over-treatment 4

Other sources of income or benefits from other organisations relevant to medical practice


Company Reason for receipt of fees Total amount received
Applied Nanodetectors Ltd Advice in 2013 about how to assess the diagnostic usefullness of their Nanaodetectors in order to predict the opitimum treatment of patients 2

Fees directly received from other medical companies


Company Reason for receipt of fees Total amount received
Oxford University Press Annual royalties from the Oxford Handbook of Clinical Diagnosis £5000 - £10000

Oct. 16, 2015

Nothing To Declare